23
Views
5
CrossRef citations to date
0
Altmetric
Review

Infection control in the intensive care unit

, , &
Pages 795-805 | Published online: 10 Jan 2014

References

  • Eggimann P, Pittet D. Infection control in the ICU. Chest 120,2059–2093 (2001).
  • •In depth review of intensive care unit (ICU)-acquired infections.
  • Vincent JL, Bihari D, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe — the results of the EPIC study. J. Am. Med. Assoc. 274, 639–644 (1995).
  • •Important study of the prevalence of ICU-acquired infection in ICUs across Europe.
  • Legras A, Malvy D, Quinioux Al, et al. Nosocomial infections: prospective survey of incidence in five French intensive care units. Intensive Care Med 24,1040–1046 (1998).
  • Girou E, Stephan F, Novara A, et al. Risk factors and outcome of nosocomial infections: results of a matched case-control study of ICU patients. Am. J. Respir Crit Care Med. 157,1151–1158 (1998).
  • Papia G, McLellan BA, El Helou P, et al. Infection in hospitalized trauma patients: incidence, risk factors, and complications. J. Trauma 47,923–927 (1999).
  • Dagan O, Cox PN, Ford-Jones L, Ponsonby J, Bohn DJ. Nosocomial infection following cardiovascular surgery: comparison of two periods, 1987 vs. 1992. Crit. Care Med. 27, 104–108 (1999).
  • Alberti C, Brun-Buisson C, Burchardi H, et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 28,108–121 (2002).
  • •Important multicentric study.
  • Nicastri E, Petrosillo N, Martini L, Larosa M, Gesu GP, Ippolito G. Prevalence of nosocomial infections in 15 Italian hospitals: first point prevalance study for the INF-NOS project. Infection 31\(Suppl. 2), 10–15 (2003).
  • Richards MJ, Edwards JR, Culver DH, Gaynes RP Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit. Care Med. 27, 887–892 (1999).
  • Pelupessy I, Bonten MJ, Diekmann O. How to assess the relative importance of different colonization routes of pathogens within hospital settings. Proc. Natl Acad Sci. USA 99,5601–5605 (2002).
  • Rangel-Frausto MS, Wiblin T, Blumberg HM, et al. National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin. Infect. Dis. 29,253–258 (1999).
  • McNeil SA, Foster CL, Hedderwick SA, Kauffman CA. Effect of hand cleansing with antimicrobial soap or alcohol-based gel on microbial colonization of artificial fingernails worn by healthcare workers. Clin. Infect. Dis. 32,367–372 (2001).
  • Pittet D, Dharan S, Touveneau S, Sauvan 821–826 (1999).
  • •Important study in the field.
  • Foca M, Jakob K, Whittier S, et al. Endemic Pseudomonas aeruginosa infection in a neonatal intensive care unit. N Engl J. Med. 343,695–700 (2000).
  • Roberts SA, Findlay R, Lang SD. Investigation of an outbreak of multidrug resistant Acinetobacter baumannii in an intensive care burns unit. J. Hosp. Infect. 48, 228–232 (2001).
  • Marco F, Lockhart SR, Pfaller MA, et al. Elucidating the origins of nosocomial infections with Candida albicans by DNA fingerprinting with the complex probe Ca3. Clin. Microbial 37,2817–2828 (1999).
  • Sole ML, Poalillo FE, Byers JF, Ludy JE. Bacterial growth in secretions and on suctioning equipment of orally intubated patients: a pilot study. Am. J. Crit Care 11, 141–149 (2002).
  • Ewig S, Torres A, El-Ebiary M, et al. Bacterial colonization patterns in mechanically ventilated patients with traumatic and medical head injury. Incidence, risk factors, and association with ventilator-associated pneumonia. Am. J. Respir Crit. Care Med 159,188–198 (1999).
  • Wang SH, Sheng WH, Chang YY, et al. Healthcare-associated outbreak due to pan-drug-resistant Acinetobacter baumannii in a surgical intensive care unit. J. Hosp. Infect. 53,97–102 (2003).
  • Steinhauser ML, Hogaboam CM, Kunkel SLS Standiford TJ, Lukacs NW. IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense. J Immunol 162,392–399 (1999).
  • Döcke WD, Randow F, Syrbe HP, et al. Monocyte deactivation in septic patients: restoration by IFN-y treatment. Nature Med 3,678–681 (1997).
  • Asadullah K, Woiciechowsky C, Docke WD, et al. Immunodepression following neurosurgical procedures. Crit Care Med. 23,1976–1983 (1995).
  • Schinkel C, Sendtner R, Zimmer S, Faist E. Functional analysis of monocyte subsets in surgical sepsis. J. Trauma 44,743–748 (1998).
  • Peters M, Petros A, Dixon G, Inwald D, Klein N. Acquired immunoparalysis in paediatric intensive care: prospective observational study. Br Med. J. 319, 609–610 (1999).
  • Fridkin SK, Pear SM, Williamson TH, Galgiani JN, Jarvis WR. The role of understaffing in central venous catheter-associated bloodstream infections. Infect. Cont. Hosp. Epidemiol 17, 150–158 (1996).
  • Vicca AF. Nursing staff workload as a determinant of methicillin-resistant Staphylococcus aureus spread in an adult intensive therapy unit. J. Hosp. Infect. 43, 109–113 (1999).
  • Robert J, Fridkin SK, Blumberg HM, et al. The influence of the composition of the nursing staff on primary bloodstream infection rates in a surgical intensive care unit. Infect. Cont. Hosp. Epidemiol 21, 12–17 (2000).
  • Appelgren P, Hellstrom I, Weitzberg E, Soderlund V, Bindslev L, Ransjo U. Risk factors for nosocomial intensive care infection: a long-term prospective analysis. Acta Anaesthesia Scand. 45,710–719 (2001).
  • Cunnion KM, Weber DJ, Broadhead WE, Hanson LC, Pieper CF, Rutala WA. Risk factors for nosocomial pneumonia: comparing adult critical-care populations. Am. J. Respir. Crit. Care Med 153,158–162 (1996).
  • Tejada AA, Bello DS, Chacon VE, et al. Risk factors for nosocomial pneumonia in critically ill trauma patients. Crit. Care Med. 29, 304–309 (2001).
  • Cook DJ, Walter SD, Cook RJ, et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann. Intern. Med. 129,433–440 (1998).
  • Richards MJ, Edwards JR, Culver DH, Gaynes RP Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect. Cont. Hosp. Epidemiol 21,510–515 (2000).
  • Rello J, 011endorf DA, Oster G, et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 122,2115–2121 (2002).
  • Ibrahim EH, Tracy L, Hill C, Fraser VJ, Kollef MH. The occurrence of ventilator-associated pneumonia in a community hospital: risk factors and clinical outcomes. Chest 120,555–561 (2001).
  • Shorr AF, Duh MS, Kelly KM, Kollef MH. Red blood cell transfusion and ventilator-associated pneumonia: a potential link? Crit. Care Med. 32, 666–674 (2004).
  • Leone M, Albanese J, Gamier F, et al. Risk factors of nosocomial catheter-associated urinary tract infection in a polyvalent intensive care unit. Intensive Care Med. 29, 1077–1080 (2003).
  • Laupland KB, Zygun DA, Davies HD, Church DL, Louie TJ, Doig CJ. Incidence and risk factors for acquiring nosocomial urinary tract infection in the critically ill. J. Crit. Care 17,50–57 (2002).
  • Hosoglu S, Akalin S, Kidir V, Suner A, Kayabas H, Geyik MF. Prospective surveillance study for risk factors of central venous catheter-related bloodstream infections. Am. J. Infect. Control 32, 131–134 (2004).
  • Oncu S, Ozsut H, Yildirim A, et al. Central venous catheter related infections: risk factors and the effect of glycopeptide antibiotics. Ann. Clin. Microbial Antimicrob. 2(1), 3 (2003).
  • Moro ML, Vigano EF, Cozzi LA. Risk factors for central venous catheter-related infections in surgical and intensive care units. The Central Venous Catheter-Related Infections Study Group. Infect. Cont. Hosp. Epidemiol 15,253–264 (1994).
  • Darouiche RO, Raad II, Heard SO, et al. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J. Med. 340,1–8 (1999).
  • Haley RW, Culver DH, White JW, et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am. J. Epidemiol 121,182–205 (1985).
  • Misset B, Timsit JF, Dumay MF, et al. A continuous quality-improvement program reduces nosocomial infection rates in the ICU. Intensive Care Med. 30,395–400 (2004).
  • •Study demonstrating benefits of infection-control practices on infection rates.
  • van Saene HK, Petros AJ, Ramsay G, Baxby D. All great truths are iconoclastic: selective decontamination of the digestive tract moves from heresy to level 1 truth. Intensive Care Med. 29,677–690 (2003).
  • Larson E. Skin hygiene and infection prevention: more of the same or different approaches? Clin. Infect. Dis. 29, 1287–1294 (1999).
  • McGuckin M. Hand hygiene accountability. Nurs. Manage. 34,2 (2003).
  • Arroliga AC, Budev MM, Gordon SM. Do as we say, not as we do: healthcare workers and hand hygiene. Crit. Care Med. 32,592–593 (2004).
  • Sproat LJ, Inglis TJ. A multicenter survey of hand hygiene practice in intensive care units. J. Hosp. Infect. 26,137–148 (1994).
  • Maury E, Alzieu M, Baudel JL, et al. Availability of an alcohol solution can improve hand disinfection compliance in an intensive care unit. Am. J. Respir. Crit. Care Med. 162,324–327 (2000).
  • Pittet D, Mourouga P, Perneger TV. Compliance with handwashing in a teaching hospital. Infection-control program. Ann. Intern. Med. 130, 126–130 (1999).
  • Boyce JM, Pittet D. Guideline for Hand Hygiene in Healthcare Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. Morbid. Mortal. Wkly Rep. Recomm. Rep. 51,1–45 (2002).
  • •Detailed evaluation of various hand-hygiene products and description of their best use.
  • Doebbeling BN, Stanley GL, Sheetz CT, et al. Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units. N Engl J. Med. 327,88–93 (1992).
  • Voss A, Widmer AF. No time for handwashing!? Handwashing versus alcoholic rub: can we afford 100% compliance? Infect. Cont. Hosp. Epidemiol 18,205–208 (1997).
  • Lankford MG, Zembower TR, Trick WE, Hacek DM, Noskin GA, Peterson LR. Influence of role models and hospital design on hand hygiene of healthcare workers. Emerg. Infect. Dis. 9,217–223 (2003).
  • Tibballs J. Teaching hospital medical staff to handwash. Med. J. Aust. 164,395–398 (1996).
  • Pittet D, Hugonnet S, Harbarth S, et al. Effectiveness of a hospital-wide program to improve compliance with hand hygiene. Infection-control program. Lancet 356,1307 —1312 (2000).
  • Swoboda SM, Earsing K, Strauss K, Lane S, Lipsett PA. Electronic monitoring and voice prompts improve hand hygiene and decrease nosocomial infections in an intermediate care unit. Crit. Care Med. 32, 358–363 (2004).
  • Van de Mortel T, Bourke R, Fillipi L, et al. Maximising handwashing rates in the critical care unit through yearly performance feedback. Aust. Crit. Care 13, 91–95 (2000).
  • TabIan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R. Guidelines for preventing healthcare-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. Morbid. Mortal. Wkly Rep. Recomm. Rep. 53, 1–36 (2004).
  • Vincent JL. Nosocomial infections in adult intensive-care units. Lancet 361, 2068–2077 (2003).
  • •Recent review.
  • Torres A, Serra-Battles J, Ros E, et al. Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: the effect of body position. Ann. Intern. Med. 116, 540–543 (1992).
  • Drakulovic MB, Torres A, Bauer TT, Nicolas JM, Nogue S, Ferrer M. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomized trial. Lancet 354, 185 1–1 858 (1999).
  • Nelson LD, Choi SC. Kinetic therapy in critically ill trauma patients. Clin. Intensive Care 3, 248–252 (1992).
  • DeBoisblanc BP, Castro M, Everret B, Grender J, Walker CD, Summer WR. Effect of air-supported, continuous, postural oscillation on the risk of early ICU pneumonia in nontraumatic critical illness. Chest 103, 1543–1547 (1993).
  • Kirschenbaum L, Azzi E, Sfeir T, Tietjen P, Astiz M. Effect of continuous lateral rotational therapy on the prevalence of ventilator-associated pneumonia in patients requiring long-term ventilatory care. Crit. Care Med. 30, 1983–1986 (2002).
  • Rouby JJ, Laurent P, Gosnach M, et al. Risk factors and clinical relevance of nosocomial maxillary sinusitis in the critically ill. Am. J. Respir. Crit. Care Med. 150, 776–783 (1994).
  • Holzapfel L, Chastang C, Demingeon G, Bohe J, Piralla B, Coupry A. A randomized study assessing the systematic search for maxillary sinusitis in nasotracheally mechanically ventilated patients. Influence of nosocomial maxillary sinusitis on the occurrence of ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med. 159, 695–701 (1999).
  • Long MN, Wickstrom G, Grimes A, Benton CF, Belcher B, Stamm AM. Prospective, randomized study of ventilator-associated pneumonia in patients with one versus three ventilator circuit changes per week. Infect. Cont. Hosp. Epidemiol. 17, 14–19 (1996).
  • Dreyfuss D, Djedaini K, Weber P, et al. Prospective study of nosocomial pneumonia and of patient and circuit colonization during mechanical ventilation with circuit changes every 48 h versus no change. Am. 1?ev. Respir. Dis. 143, 738–743 (1991).
  • Kirton OC, DeHaven BMJ, Morejon O, Civetta J. A prospective, randomized comparison of an in-line heat moisture exchange filter and heated wire humidifiers: rates of ventilator-associated early onset (community acquired) or late-onset (hospital-acquired) pneumonia and incidence of endotracheal tube occlusion. Chest 112, 1055–1059 (1997).
  • Dreyfuss D, Djedaini K, Gros I, et al. Mechanical ventilation with heated humidifiers or heat and moisture exchangers: effects on patient colonization and incidence of nosocomial pneumonia. Am. J. Respir. Crit. Care Med 151, 986–992 (1995).
  • Valles J, Artigas A, Rello J, et al. Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia. Ann. Intern. Med. 122, 179–186 (1995).
  • Kollef MH, Skubas NJ, Sundt TM. A randomized clinical trial of continuous aspiration of subglottic secretions in cardiac surgery patients. Chest 116, 1339–1346 (1999).
  • Shorr AF, O'Malley PG. Continuous subglottic suctioning for the prevention of ventilator-associated pneumonia: potential economic implications. Chest 119, 228–235 (2001).
  • Nourdine K, Combes P, Carton MJ, Beuret P, Cannamela A, Ducreux JC. Does noninvasive ventilation reduce the ICU nosocomial infection risk? A prospective clinical survey. Intensive Care Med. 25, 567–573 (1999).
  • Guerin C, Girard R, Chemorin C, De Varax R, Fournier G. Facial mask noninvasive mechanical ventilation reduces the incidence of nosocomial pneumonia. A prospective epidemiological survey from a single ICU. Intensive Care Med. 23, 1024–1032 (1997).
  • Girou E, Schortgen F, Deldaux C, et al. Association of noninvasive ventilation with nosocomial infections and survival in critically ill patients. J. Am. Med. Assoc. 284, 2361–2367 (2000).
  • Driks MR, Craven DE, Celli BR, et al. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine Type 2 blockers. The role of gastric colonization. N Engl J. Med 317, 1376–1382 (1987).
  • Cook D, Guyatt G, Marshall J, et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J. Med. 338, 791–797 (1998).
  • Bonten MJ, Brun-Buisson C, Weinstein RA. Selective decontamination of the digestive tract: to stimulate or stifle? Intensive Care Med. 29, 672–676 (2003).
  • Kollef MH. The role of selective digestive tract decontamination on mortality and respiratory tract infections. A meta-analysis. Chest 105, 1101–1108 (1994).
  • Quinio B, Albanese J, Bues-Charbit M, Viviand X, Martin C. Selective decontamination of the digestive tract in multiple trauma patients. A prospective double-blind, randomized, placebo-controlled study. Chest 109, 765–772 (1996).
  • Vandenbroucke-Grauls CM, Vandenbroucke JP. Effect of selective decontamination of the digestive tract on respiratory tract infections and mortality in the intensive care unit. Lancet 338, 859–862 (1991).
  • d'Amico R, Pifferi S, Leonetti C, Torn i V, Tinazzi A, Liberati A. Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomized controlled trials. Br. Med. J. 316, 1275–1285 (1998).
  • Krueger WA, Lenhart FP, Neeser G, et al. Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical trial. Am. J. Respir Crit. Care Med. 166, 1029–1037 (2002).
  • Ferrer M, Torres A, Gonzalez J, et al. Utility of selective digestive decontamination in mechanically ventilated patients. Ann. Intern. Med. 120,389–395 (1994).
  • Nathens AB, Marshall JC. Selective decontamination of the digestive tract in surgical patients: a systematic review of the evidence. Arch. Surg 134, 170–176 (1999).
  • de Jonge E, Schultz MJ, Spanjaard L, et al. Effects of selective decontamination of the digestive tract on mortality and the acquisition of resistant bacteria in intensive care patients. Lancet 362, 1011–1016 (2003).
  • •Important randomized controlled study showing reduced mortality rates with use of selective digestive decontamination in mechanically ventilated patients.
  • Nardi G, Valentinis U, Proietti A, et al. Epidemiological impact of prolonged systematic use of topical SDD on bacterial colonization of the tracheobronchial tree and antibiotic resistance. Intensive Care Med. 19,273–278 (1993).
  • Vincent JL. Selective digestive decontamination: for everyone, everywhere? Lancet 362, 1006–1007 (2003).
  • Ahearn DG, Grace DT, Jennings MJ, et al. Effects of hydrogel/silver coatings on in vitro adhesion to catheters of bacteria associated with urinary tract infections. Curr. Microbial 41,120–125 (2000).
  • Bologna RA, Tu LM, Polansky M, Fraimow HD, Gordon DA, Whitmore KE. Hydrogel/silver ion-coated urinary catheter reduces nosocomial urinary tract infection rates in intensive care unit patients: a multicenter study. Urology 54, 982–987 (1999).
  • Karchmer TB, Giannetta ET, Muto CA, Strain BA, Farr BM. A randomized crossover study of silver-coated urinary catheters in hospitalized patients. Arch. Intern. Med. 160,3294–3298 (2000).
  • Thibon P, Le Catour X, Leroyer R, Fabry J. Randomized multicenter trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital-acquired urinary tract infections. J. Hosp. Infect. 45,117–124 (2000).
  • Saint S, Elmore JG, Sullivan SD, Emerson SS, Koepsell TD. The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection: a meta-analysis. Am. J. Med. 105,236–241 (1998).
  • Leone M, Gamier F, Antonini F, Bimar MC, Albanese J, Martin C. Comparison of effectiveness of two urinary drainage systems in intensive care unit: a prospective, randomized clinical trial. Intensive Care Med. 29,410–413 (2003).
  • Dimick JB, Pelz RK, Consunji R, Swoboda SM, Hendrix CW, Lipsett PA. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch. Surg. 136,229–234 (2001).
  • O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Infect. Cont. Hosp. Epidemiol 23,759–769 (2002).
  • •Evidence-based guidelines for the prevention of catheter-related infection.
  • Polderman KH, Girbes J. Central venous catheter use. Part 2: infectious complications. Intensive Care Med. 28, 18–28 (2002).
  • Raad II, Hohn DC, Gilbreath BJ, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect. Cont. Hosp. Epidemiol 15,231–238 (1994).
  • Rijnders BJ, Van Wijngaerden E, Wilmer A, Peetermans WE. Use of full sterile barrier precautions during insertion of arterial catheters: a randomized trial. Clin. Infect. Dis. 36,743–748 (2003).
  • Merrer J, De Jonghe B, Golliot F, et al. Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. J. Am. Med. Assoc. 286,700–707 (2001).
  • Timsit JF, Sebille V, Farkas JC, et al. Effect of subcutaneous tunneling on internal jugular catheter-related sepsis in critically ill patients: a prospective randomized multicenter study. J. Am. Med. Assoc. 276, 1416–1420 (1996).
  • Timsit JF, Bruneel F, Cheval C, et al. Use of tunneled femoral catheters to prevent catheter-related infection. A randomized, controlled trial. Ann. Intern. Med. 130, 729–735 (1999).
  • Randolph AG, Cook DJ, Gonzales CA, Brun-Buisson C. Tunneling short-term central venous catheters to prevent catheter-related infection: a meta-analysis of randomized, controlled trials. Crit. Care Med. 26,1452–1457 (1998).
  • Cobb DK, High KP, Sawyer RG, et al. A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters. N Engl J. Med. 327, 1062–1068 (1992).
  • Chen YY, Yen DH, Yang YG, Liu CY, Wang FD, Chou P Comparison between replacement at 4 days and 7 days of the infection rate for pulmonary artery catheters in an intensive care unit. Crit. Care Med. 31,1353–1358 (2003).
  • Veenstra DL, Saint S, Saha S, Lumley T, Sullivan SD. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. J. Am. Med. Assoc. 281,261–267 (1999).
  • Veenstra DL, Saint S, Sullivan SD. Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection. J. Am. Med. Assoc. 282,554–560 (1999).
  • Raad I, Darouiche R, Dupuis J, et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann. Intern. Med 127,267–274 (1997).
  • Hanna HA, Raad II, Hackett B, et al. Antibiotic-impregnated catheters associated with significant decrease in nosocomial and multidrug-resistant bacteremias in critically ill patients. Chest 124,1030–1038 (2003).
  • Carrasco MN, Bueno A, de las CC, et al. Evaluation of a triple-lumen central venous heparin-coated catheter versus a catheter coated with chlorhexidine and silver sulfadiazine in critically ill patients. Intensive Care Med 30,633–638 (2004).
  • Marciante KD, Veenstra DL, Lipsky BA, Saint S. Which antimicrobial impregnated central venous catheter should we use? Modeling the costs and outcomes of antimicrobial catheter use. Am. J. Infect. Control 31,1–8 (2003).
  • Brossette SE, Sprague AP, Jones WT, Moser SA. A data mining system for infection control surveillance. Methods Inf: Med 39, 303–310 (2000).
  • Coopersmnh CM, Rebmann TL, Zack JE, et al. Effect of an education program on decreasing catheter-related bloodstream infections in the surgical intensive care unit. Crit. Care Med 30,59–64 (2002).
  • Zack JE, Garrison T, Trovillion E, et al. Effect of an education program aimed at reducing the occurrence of ventilator-associated pneumonia. Crit. Care Med. 30,2407–2412 (2002).
  • Coopersmith CM, Zack JE, Ward MR, et al. The impact of bedside behavior on catheter-related bacteremia in the intensive care unit. Arch. Sulg. 139,131–136 (2004).
  • Rosenthal VD, Guzman S, Pezzotto SM, Cmich CJ. Effect of an infection-control program using education and performance feedback on rates of intravascular device-associated bloodstream infections in intensive care units in Argentina. Am. J. Infect. Control31, 405–409 (2003).
  • Rosenthal VD, Guzman S, Safdar N. Effect of education and performance feedback on rates of catheter-associated urinary tract infection in intensive care units in Argentina. Infect. Cont. Hosp. Epidemiol 25,47–50 (2004).
  • Venberghe A, Laterre P, Goenen M, et al. Surveillance of hospital-acquired infections in an intensive care department — the benefit of the full-time presence of an infection-control nurse. J. Hosp. Infect. 52, 56–59 (2002).
  • National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1992 — June 2001, issued August 2001. Am. J. Infect. Control 29, 404–421 (2001).
  • Archibald L, Phillips L, Monnet D, McGowan JEJ, Tenover F, Gaynes R. Antimicrobial resistance in isolates from in-patients and out-patients in the United States: increasing importance of the intensive care unit. Clin. Infect. Dis. 24, 211–215 (1997).
  • Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Surveillance Report, data summary from January 1996 through December 1997: a report from the National Nosocomial Infections Surveillance (NNIS) System. Am. J. Infect. Control 27, 279–284 (1999).
  • Trouillet JL, Chastre J, Vuagnat A, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am. J. Respir. Crit. Care Med. 157, 531–539 (1998).
  • Fagon JY, Chastre J, Wolff M, et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann. Intern. Med. 132, 621–630 (2000).
  • McGowan JE Jr. Minimizing antimicrobial resistance: the key role of the infectious diseases physician. Clin. Infect. Dis. 38, 939–942 (2004).
  • Cornaglia G, Hryniewicz W Jarlier V, et al . European recommendations for antimicrobial resistance surveillance. Clin. Microbial Infict. 10, 349–383 (2004).
  • Warren DK, Fraser VJ. Infection-control measures to limit antimicrobial resistance. Crit. Care Med 29, N128—N134 (2001).
  • Gruson D, Hilbert G, Vargas F, et al. Impact of colony-stimulating factor therapy on clinical outcome and frequency rate of nosocomial infections in intensive care unit neutropenic patients. Crit. Cam Med 28, 3155–3160(2000).
  • Raymond DP, Pelletier SJ, Crabtree TD, et al. Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit. Crit. Care Med 29, 1101–1108 (2001).
  • Kollef MH, Vlasnik J, Sharpless L, Pasque C, Murphy D, Fraser V Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia. Am. J Respir. Crit. Care Med 156, 1040–1048 (1997).

Websites

  • National Nosocomial Infection Surveillance System www.cdc.govincidocUhip/NNIS/@nnis.htm (Accessed September 2004)
  • Hospitals in Europe Link for Infection Control through Surveillance (HELICS) project helics.univ-lyonl.fr/index.htm (Accessed September 2004)
  • Hospisafe www.hopisafe.ch (Accessed September 2004)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.